emerging data for the treatment of her2 mbc
Published 4 years ago • 107 plays • Length 3:59Download video MP4
Download video MP3
Similar videos
-
6:06
combining anti-her2 agents with immunotherapy for her2 mbc
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
5:48
what’s new for her2 mbc?
-
4:06
her2 positive mbc emerging treatment landscape
-
6:41
the emerging role of neratinib in her2 mbc
-
56:42
research update for her2-positive mbc | 2021-2022 embrace mbc virtual forum series
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
14:45
management of adverse effects in r/r her2 mbc
-
13:09
get all the info you need about her2 ve breast cancer - her2 ve breast cancer || dr liz o'riordan
-
53:12
stage 4 breast cancer - part 3/4 - "treatment of stage 4, her2 positive breast cancers"
-
51:38
medical update: her2-positive and triple-positive metastatic breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
51:56
new & supporting data for optimizing therapy in her2 breast cancer | dr. kaklamani and dr. o’regan
-
3:43
evolving role of trastuzumab deruxtecan in her2 /her2-low mbc
-
1:09
the exciting new field of her2-low breast cancer
-
52:21
new & supporting data for optimizing therapy in her2 breast cancer | dr. irene and dr. vogel
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
3:13
ac versus taxac in high-risk her2-negative mbc
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar